BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9952300)

  • 1. Wortmannin sensitizes mammalian cells to radiation by inhibiting the DNA-dependent protein kinase-mediated rejoining of double-strand breaks.
    Chernikova SB; Wells RL; Elkind MM
    Radiat Res; 1999 Feb; 151(2):159-66. PubMed ID: 9952300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2.
    Wang H; Zeng ZC; Bui TA; DiBiase SJ; Qin W; Xia F; Powell SN; Iliakis G
    Cancer Res; 2001 Jan; 61(1):270-7. PubMed ID: 11196174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.
    Sarkaria JN; Tibbetts RS; Busby EC; Kennedy AP; Hill DE; Abraham RT
    Cancer Res; 1998 Oct; 58(19):4375-82. PubMed ID: 9766667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inactivation of DNA-dependent protein kinase with antisense oligodeoxynucleotides: consequences for the rejoining of radiation-induced DNA double-strand breaks and radiosensitivity of human cancer cell lines.
    Sak A; Stuschke M; Wurm R; Schroeder G; Sinn B; Wolf G; Budach V
    Cancer Res; 2002 Nov; 62(22):6621-4. PubMed ID: 12438258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wortmannin inhibits repair of DNA double-strand breaks in irradiated normal human cells.
    Okayasu R; Suetomi K; Ullrich RL
    Radiat Res; 1998 May; 149(5):440-5. PubMed ID: 9588354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the radiosensitizing effect of wortmannin, DNA double-strand break rejoining, and p21WAF1 induction in human normal and tumor-derived cells.
    Mirzayans R; Pollock S; Scott A; Enns L; Andrais B; Murray D
    Mol Carcinog; 2004 Mar; 39(3):164-72. PubMed ID: 14991746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wortmannin enhances the induction of micronuclei by low and high LET radiation.
    Oliveira NG; Castro M; Rodrigues AS; Gonçalves IC; Gil OM; Fernandes AP; Toscano-Rico JM; Rueff J
    Mutagenesis; 2003 Jan; 18(1):37-44. PubMed ID: 12473733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SU11752 inhibits the DNA-dependent protein kinase and DNA double-strand break repair resulting in ionizing radiation sensitization.
    Ismail IH; Mårtensson S; Moshinsky D; Rice A; Tang C; Howlett A; McMahon G; Hammarsten O
    Oncogene; 2004 Jan; 23(4):873-82. PubMed ID: 14661061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-PK: the major target for wortmannin-mediated radiosensitization by the inhibition of DSB repair via NHEJ pathway.
    Hashimoto M; Rao S; Tokuno O; Yamamoto K; Takata M; Takeda S; Utsumi H
    J Radiat Res; 2003 Jun; 44(2):151-9. PubMed ID: 13678345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Wortmannin on the repair profiles of DNA double-strand breaks in the whole genome and in interstitial telomeric sequences of Chinese hamster cells.
    Losada R; Rivero MT; Slijepcevic P; Goyanes V; Fernández JL
    Mutat Res; 2005 Feb; 570(1):119-28. PubMed ID: 15680409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.
    Rosenzweig KE; Youmell MB; Palayoor ST; Price BD
    Clin Cancer Res; 1997 Jul; 3(7):1149-56. PubMed ID: 9815794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1.
    Veuger SJ; Curtin NJ; Richardson CJ; Smith GC; Durkacz BW
    Cancer Res; 2003 Sep; 63(18):6008-15. PubMed ID: 14522929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication protein A2 phosphorylation after DNA damage by the coordinated action of ataxia telangiectasia-mutated and DNA-dependent protein kinase.
    Wang H; Guan J; Wang H; Perrault AR; Wang Y; Iliakis G
    Cancer Res; 2001 Dec; 61(23):8554-63. PubMed ID: 11731442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus.
    DiBiase SJ; Zeng ZC; Chen R; Hyslop T; Curran WJ; Iliakis G
    Cancer Res; 2000 Mar; 60(5):1245-53. PubMed ID: 10728683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin.
    Christodoulopoulos G; Muller C; Salles B; Kazmi R; Panasci L
    Cancer Res; 1998 May; 58(9):1789-92. PubMed ID: 9581813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A targeted inhibition of DNA-dependent protein kinase sensitizes breast cancer cells following ionizing radiation.
    Kim CH; Park SJ; Lee SH
    J Pharmacol Exp Ther; 2002 Nov; 303(2):753-9. PubMed ID: 12388662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactive effects of inhibitors of poly(ADP-ribose) polymerase and DNA-dependent protein kinase on cellular responses to DNA damage.
    Boulton S; Kyle S; Durkacz BW
    Carcinogenesis; 1999 Feb; 20(2):199-203. PubMed ID: 10069454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homologous recombination as a potential target for caffeine radiosensitization in mammalian cells: reduced caffeine radiosensitization in XRCC2 and XRCC3 mutants.
    Asaad NA; Zeng ZC; Guan J; Thacker J; Iliakis G
    Oncogene; 2000 Nov; 19(50):5788-800. PubMed ID: 11126366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactive competition between homologous recombination and non-homologous end joining.
    Allen C; Halbrook J; Nickoloff JA
    Mol Cancer Res; 2003 Oct; 1(12):913-20. PubMed ID: 14573792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs.
    Shinohara ET; Geng L; Tan J; Chen H; Shir Y; Edwards E; Halbrook J; Kesicki EA; Kashishian A; Hallahan DE
    Cancer Res; 2005 Jun; 65(12):4987-92. PubMed ID: 15958537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.